Results 1 to 10 of about 3,641 (145)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Caracterización de las reacciones adversas medicamentosas en ancianos. Matanzas. 2005-2009 Characterization of the adverse drug reactions in elder people. Matanzas. 2005-2009

Revista Médica Electrónica, 2011
La presente investigación caracterizó las notificaciones de sospechas de reacciones adversas medicamentosas en personas mayores de 60 años, recibidas en la Unidad Coordinadora Provincial de Farmacovigilancia, desde el 1 de enero de 2005 al 31 de ...
Leidy Santos Muñoz, Legdy Mari Martínez Padrón   +1 more
doaj  

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

Patient Preference and Adherence
Carlos De las Cuevas,1 Emilio J Sanz,2,3 Jose de Leon4,5 1Department of Internal Medicine, Dermatology, and Psychiatry and Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, La Laguna, Canary Islands, Spain; 2Department of Physical
De las Cuevas C, Sanz EJ, de Leon J
doaj  

Falsificação de medicamentos no Brasil Falsificación de medicamentos en Brasil Counterfeiting of drugs in Brazil

Revista de Saúde Pública, 2012
OBJETIVO: Identificar os principais medicamentos falsificados apreendidos pela Polícia Federal brasileira e os estados em que houve a apreensão. MÉTODOS: Estudo retrospectivo descritivo dos laudos periciais elaborados por Peritos Criminais da Polícia ...
Joseane Ames, Daniele Zago Souza
doaj  

Introducing auto-disable syringes to the national immunization programme in Madagascar

Bulletin of the World Health Organization, 2003
OBJECTIVE: To evaluate the safety and coverage benefits of auto-disable (AD) syringes, weighed against the financial and logis- tical costs, and to create appropriate health policies in Madagascar.
Drain Paul K., Ralaivao Josoa S., Rakotonandrasana Alexander, Carnell Mary A.   +3 more
doaj  

Postmarketing surveillance Is not used to promote products: Avoid promotional studies [PDF]

BMJ, 1994
openaire   +1 more source

Adverse events associated with use of immunoglobulin in pediatric patients reported to the US Food and Drug Administration Adverse Event Reporting System, 2001-2023. [PDF]

Pediatr Allergy Immunol
Wei S, Kim Y, Rubin MN, Ayyala SS, Welsh K.   +4 more
europepmc   +1 more source

Premarket and postmarket real-world evidence studies supporting U.S. Food and Drug Administration regulatory decision-making, 2016-2024. [PDF]

Clin Trials
Li LY, Ramachandran R, Ross JS, Wallach JD.   +3 more
europepmc   +1 more source

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan. [PDF]

Front Psychiatry
Takekita Y, Umeyama M, Iwaida M, Higashikawa M, Shimada Y, Nakajima A.   +5 more
europepmc   +1 more source

Evolving Real-World Data and Evidence Use for New Drugs and Regenerative Medical Products Approvals in Japan-An Analysis of the 6-Year Trend. [PDF]

Clin Pharmacol Ther
Okami S, Shimotsumagari K, Sadatsuki Y.
europepmc   +1 more source